

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of digestive system process (GO:0060456) | 9.80664466 |
| 2 | negative regulation of heart rate (GO:0010459) | 9.47581785 |
| 3 | regulation of glucocorticoid secretion (GO:2000849) | 9.37543753 |
| 4 | positive regulation of steroid hormone secretion (GO:2000833) | 8.20043636 |
| 5 | regulation of corticosteroid hormone secretion (GO:2000846) | 7.72731737 |
| 6 | positive regulation of renal sodium excretion (GO:0035815) | 6.43811839 |
| 7 | regulation of action potential (GO:0098900) | 6.00066419 |
| 8 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 5.61959103 |
| 9 | ovulation cycle (GO:0042698) | 5.56942104 |
| 10 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 5.42076225 |
| 11 | negative regulation of heart contraction (GO:0045822) | 5.25148718 |
| 12 | regulation of steroid hormone secretion (GO:2000831) | 5.19970781 |
| 13 | L-glutamate transport (GO:0015813) | 4.88794584 |
| 14 | positive regulation of acute inflammatory response (GO:0002675) | 4.81785845 |
| 15 | regulation of phospholipase A2 activity (GO:0032429) | 4.77861618 |
| 16 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 4.68181065 |
| 17 | acidic amino acid transport (GO:0015800) | 4.50520684 |
| 18 | positive regulation of catecholamine secretion (GO:0033605) | 4.22322427 |
| 19 | regulation of renal sodium excretion (GO:0035813) | 4.11517915 |
| 20 | regulation of superoxide anion generation (GO:0032928) | 4.00487974 |
| 21 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.82496122 |
| 22 | polyketide metabolic process (GO:0030638) | 3.80177854 |
| 23 | doxorubicin metabolic process (GO:0044598) | 3.80177854 |
| 24 | daunorubicin metabolic process (GO:0044597) | 3.80177854 |
| 25 | C4-dicarboxylate transport (GO:0015740) | 3.77408672 |
| 26 | regulation of podosome assembly (GO:0071801) | 3.66692909 |
| 27 | negative regulation of blood circulation (GO:1903523) | 3.63769969 |
| 28 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.59269529 |
| 29 | regulation of vitamin metabolic process (GO:0030656) | 3.51254514 |
| 30 | regulation of excretion (GO:0044062) | 3.46747085 |
| 31 | germinal center formation (GO:0002467) | 3.43087929 |
| 32 | early endosome to late endosome transport (GO:0045022) | 3.35423198 |
| 33 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.32490726 |
| 34 | cardiac left ventricle morphogenesis (GO:0003214) | 3.31177714 |
| 35 | long-term memory (GO:0007616) | 3.26242112 |
| 36 | regulation of memory T cell differentiation (GO:0043380) | 3.24924922 |
| 37 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.24366792 |
| 38 | negative regulation of meiosis (GO:0045835) | 3.19564948 |
| 39 | positive regulation of heat generation (GO:0031652) | 3.18200752 |
| 40 | regulation of digestive system process (GO:0044058) | 3.15875190 |
| 41 | tongue development (GO:0043586) | 3.11693089 |
| 42 | positive regulation of vesicle fusion (GO:0031340) | 3.10066524 |
| 43 | galactose catabolic process (GO:0019388) | 3.09905945 |
| 44 | regulation of endocrine process (GO:0044060) | 3.06820669 |
| 45 | peptide biosynthetic process (GO:0043043) | 3.06050021 |
| 46 | response to morphine (GO:0043278) | 3.01732944 |
| 47 | positive regulation of cell cycle checkpoint (GO:1901978) | 3.01396531 |
| 48 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.01148076 |
| 49 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.01148076 |
| 50 | microtubule nucleation (GO:0007020) | 2.97407479 |
| 51 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.93921162 |
| 52 | GTP biosynthetic process (GO:0006183) | 2.90124658 |
| 53 | response to phenylpropanoid (GO:0080184) | 2.88779994 |
| 54 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.87225195 |
| 55 | cellular modified amino acid catabolic process (GO:0042219) | 2.85592201 |
| 56 | response to pain (GO:0048265) | 2.85215258 |
| 57 | response to isoquinoline alkaloid (GO:0014072) | 2.84518722 |
| 58 | regulation of circadian sleep/wake cycle, sleep (GO:0045187) | 2.84310438 |
| 59 | regulation of circadian sleep/wake cycle (GO:0042749) | 2.84310438 |
| 60 | protein insertion into membrane (GO:0051205) | 2.81568895 |
| 61 | response to peptidoglycan (GO:0032494) | 2.80783573 |
| 62 | positive regulation of osteoclast differentiation (GO:0045672) | 2.80366705 |
| 63 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.77150606 |
| 64 | negative regulation of membrane potential (GO:0045837) | 2.75880601 |
| 65 | regulation of feeding behavior (GO:0060259) | 2.75458315 |
| 66 | regulation of fever generation (GO:0031620) | 2.73148602 |
| 67 | neuronal action potential propagation (GO:0019227) | 2.71063424 |
| 68 | glucosamine-containing compound catabolic process (GO:1901072) | 2.66795222 |
| 69 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.64675852 |
| 70 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.62545771 |
| 71 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.62545771 |
| 72 | modulation by symbiont of host immune response (GO:0052553) | 2.62545771 |
| 73 | positive regulation by symbiont of host defense response (GO:0052509) | 2.62545771 |
| 74 | modulation by symbiont of host defense response (GO:0052031) | 2.62545771 |
| 75 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.62545771 |
| 76 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.58996082 |
| 77 | negative regulation of neurological system process (GO:0031645) | 2.58799526 |
| 78 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.58024126 |
| 79 | glutathione biosynthetic process (GO:0006750) | 2.57470806 |
| 80 | positive regulation of catenin import into nucleus (GO:0035413) | 2.57367896 |
| 81 | signal peptide processing (GO:0006465) | 2.57052927 |
| 82 | positive regulation of bone resorption (GO:0045780) | 2.53498360 |
| 83 | positive regulation of bone remodeling (GO:0046852) | 2.53498360 |
| 84 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.52469843 |
| 85 | positive regulation of circadian rhythm (GO:0042753) | 2.51245397 |
| 86 | regulation of prostaglandin secretion (GO:0032306) | 2.51139084 |
| 87 | UTP biosynthetic process (GO:0006228) | 2.50686116 |
| 88 | cellular extravasation (GO:0045123) | 2.48198835 |
| 89 | galactose metabolic process (GO:0006012) | 2.47624722 |
| 90 | post-embryonic morphogenesis (GO:0009886) | 2.47228241 |
| 91 | negative regulation of mast cell activation (GO:0033004) | 2.46180556 |
| 92 | response to manganese ion (GO:0010042) | 2.42574956 |
| 93 | protein prenylation (GO:0018342) | 2.41668164 |
| 94 | prenylation (GO:0097354) | 2.41668164 |
| 95 | embryonic placenta development (GO:0001892) | 2.36966775 |
| 96 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.36901434 |
| 97 | cytokine secretion (GO:0050663) | 2.36559963 |
| 98 | positive regulation of action potential (GO:0045760) | 13.4798227 |
| 99 | tachykinin receptor signaling pathway (GO:0007217) | 12.8020416 |
| 100 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 11.5900834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 6.45390977 |
| 2 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 4.74115001 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.19954482 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.83934141 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.15294055 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.76673250 |
| 7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.45531872 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.43570790 |
| 9 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.39603986 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.38714751 |
| 11 | FUS_26573619_Chip-Seq_HEK293_Human | 2.30550811 |
| 12 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.26013032 |
| 13 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 2.24931712 |
| 14 | AHR_22903824_ChIP-Seq_MCF-7_Human | 2.17013147 |
| 15 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.16497463 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.11962736 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.10468156 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.09105726 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.07903278 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.05850825 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.02598869 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.97223125 |
| 23 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.96088051 |
| 24 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.95541980 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.89242299 |
| 26 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.83532869 |
| 27 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.83137273 |
| 28 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.80748248 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.70786141 |
| 30 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.69521167 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.67945731 |
| 32 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.66251482 |
| 33 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.58258453 |
| 34 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.57150384 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.56070970 |
| 36 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.52273960 |
| 37 | CJUN_26792858_Chip-Seq_BT549_Human | 1.50381233 |
| 38 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.48666764 |
| 39 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.43625825 |
| 40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.38285469 |
| 41 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32774557 |
| 42 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.32439242 |
| 43 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.31033086 |
| 44 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.31033086 |
| 45 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.30541298 |
| 46 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.26684029 |
| 47 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.26136804 |
| 48 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.25141013 |
| 49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24325668 |
| 50 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.24031427 |
| 51 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.22164134 |
| 52 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.21380322 |
| 53 | GF1_26923725_Chip-Seq_HPCs_Mouse | 1.19806151 |
| 54 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.19496020 |
| 55 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.17927684 |
| 56 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.16931013 |
| 57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16811510 |
| 58 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.16653386 |
| 59 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.15486959 |
| 60 | AR_20517297_ChIP-Seq_VCAP_Human | 1.15189480 |
| 61 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.14963477 |
| 62 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.14176040 |
| 63 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.12542424 |
| 64 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.11809393 |
| 65 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.10286682 |
| 66 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.09887754 |
| 67 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.09318746 |
| 68 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09149705 |
| 69 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.07747265 |
| 70 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.07568122 |
| 71 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.06326132 |
| 72 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.05954035 |
| 73 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.04871062 |
| 74 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.04789953 |
| 75 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04465318 |
| 76 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.03824345 |
| 77 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.03824345 |
| 78 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.03476076 |
| 79 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.02691708 |
| 80 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02581905 |
| 81 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.02010016 |
| 82 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02006190 |
| 83 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.01421266 |
| 84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01063484 |
| 85 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.99429417 |
| 86 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99020958 |
| 87 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.98938139 |
| 88 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98452417 |
| 89 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98307737 |
| 90 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.97399707 |
| 91 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97181444 |
| 92 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97046772 |
| 93 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.96594769 |
| 94 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96511073 |
| 95 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.95895097 |
| 96 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.95638509 |
| 97 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.94582076 |
| 98 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.94134803 |
| 99 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.93779897 |
| 100 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93084487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010386_abnormal_urinary_bladder | 9.15509974 |
| 2 | MP0009379_abnormal_foot_pigmentation | 7.12615858 |
| 3 | MP0003879_abnormal_hair_cell | 2.99123325 |
| 4 | MP0000383_abnormal_hair_follicle | 2.98831667 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.57318410 |
| 6 | MP0000579_abnormal_nail_morphology | 2.43139606 |
| 7 | MP0001853_heart_inflammation | 2.23446068 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.23414364 |
| 9 | MP0008995_early_reproductive_senescence | 2.15739050 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 2.15621242 |
| 11 | MP0009785_altered_susceptibility_to | 2.11279395 |
| 12 | MP0005360_urolithiasis | 2.00249618 |
| 13 | MP0003880_abnormal_central_pattern | 1.99159884 |
| 14 | MP0003303_peritoneal_inflammation | 1.95922228 |
| 15 | MP0004947_skin_inflammation | 1.93249746 |
| 16 | MP0010678_abnormal_skin_adnexa | 1.88862401 |
| 17 | MP0003950_abnormal_plasma_membrane | 1.85884630 |
| 18 | MP0005423_abnormal_somatic_nervous | 1.81627246 |
| 19 | MP0005058_abnormal_lysosome_morphology | 1.79068526 |
| 20 | MP0001501_abnormal_sleep_pattern | 1.74518655 |
| 21 | MP0001986_abnormal_taste_sensitivity | 1.71895211 |
| 22 | MP0009053_abnormal_anal_canal | 1.65076064 |
| 23 | MP0002332_abnormal_exercise_endurance | 1.55939292 |
| 24 | MP0003436_decreased_susceptibility_to | 1.52262807 |
| 25 | MP0009764_decreased_sensitivity_to | 1.51838874 |
| 26 | MP0008775_abnormal_heart_ventricle | 1.50695623 |
| 27 | MP0000343_altered_response_to | 1.48961868 |
| 28 | MP0001756_abnormal_urination | 1.47082019 |
| 29 | MP0000538_abnormal_urinary_bladder | 1.45292988 |
| 30 | MP0009278_abnormal_bone_marrow | 1.42595457 |
| 31 | MP0002736_abnormal_nociception_after | 1.39778443 |
| 32 | MP0009384_cardiac_valve_regurgitation | 1.35276098 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.34938882 |
| 34 | MP0005671_abnormal_response_to | 1.34203551 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.32120940 |
| 36 | MP0003075_altered_response_to | 1.30036918 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.29350680 |
| 38 | MP0000685_abnormal_immune_system | 1.27436363 |
| 39 | MP0001177_atelectasis | 1.27423665 |
| 40 | MP0006082_CNS_inflammation | 1.22140173 |
| 41 | MP0009765_abnormal_xenobiotic_induced | 1.22048563 |
| 42 | MP0008875_abnormal_xenobiotic_pharmacok | 1.18956645 |
| 43 | MP0001764_abnormal_homeostasis | 1.17485108 |
| 44 | MP0006072_abnormal_retinal_apoptosis | 1.15973103 |
| 45 | MP0002419_abnormal_innate_immunity | 1.15599799 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.14777880 |
| 47 | MP0002006_tumorigenesis | 1.13782196 |
| 48 | MP0002723_abnormal_immune_serum | 1.10499220 |
| 49 | MP0001968_abnormal_touch/_nociception | 1.06035528 |
| 50 | MP0001970_abnormal_pain_threshold | 1.03439402 |
| 51 | MP0005332_abnormal_amino_acid | 0.98759392 |
| 52 | MP0001790_abnormal_immune_system | 0.98518548 |
| 53 | MP0005387_immune_system_phenotype | 0.98518548 |
| 54 | MP0004147_increased_porphyrin_level | 0.97759380 |
| 55 | MP0000858_altered_metastatic_potential | 0.96792381 |
| 56 | MP0001800_abnormal_humoral_immune | 0.96408562 |
| 57 | MP0008469_abnormal_protein_level | 0.95493401 |
| 58 | MP0003091_abnormal_cell_migration | 0.94665641 |
| 59 | MP0008877_abnormal_DNA_methylation | 0.92521595 |
| 60 | MP0002998_abnormal_bone_remodeling | 0.91728128 |
| 61 | MP0004782_abnormal_surfactant_physiolog | 0.89902019 |
| 62 | MP0000427_abnormal_hair_cycle | 0.87482126 |
| 63 | MP0004270_analgesia | 0.87379209 |
| 64 | MP0010155_abnormal_intestine_physiology | 0.87043778 |
| 65 | MP0001486_abnormal_startle_reflex | 0.85435530 |
| 66 | MP0005025_abnormal_response_to | 0.84579401 |
| 67 | MP0001849_ear_inflammation | 0.82207133 |
| 68 | MP0005166_decreased_susceptibility_to | 0.82003766 |
| 69 | MP0005670_abnormal_white_adipose | 0.81929899 |
| 70 | MP0000013_abnormal_adipose_tissue | 0.81292824 |
| 71 | MP0009763_increased_sensitivity_to | 0.79163640 |
| 72 | MP0000358_abnormal_cell_content/ | 0.78804840 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 0.77542182 |
| 74 | MP0001845_abnormal_inflammatory_respons | 0.77216474 |
| 75 | MP0002254_reproductive_system_inflammat | 0.75287568 |
| 76 | MP0003786_premature_aging | 0.74855184 |
| 77 | MP0001533_abnormal_skeleton_physiology | 0.74577179 |
| 78 | MP0000569_abnormal_digit_pigmentation | 0.74526306 |
| 79 | MP0009840_abnormal_foam_cell | 0.73354601 |
| 80 | MP0003300_gastrointestinal_ulcer | 0.73100170 |
| 81 | MP0003195_calcinosis | 0.72570159 |
| 82 | MP0005076_abnormal_cell_differentiation | 0.71963351 |
| 83 | MP0005197_abnormal_uvea_morphology | 0.71201097 |
| 84 | MP0001819_abnormal_immune_cell | 0.69034219 |
| 85 | MP0001881_abnormal_mammary_gland | 0.67967558 |
| 86 | MP0005085_abnormal_gallbladder_physiolo | 0.66770222 |
| 87 | MP0002420_abnormal_adaptive_immunity | 0.66096572 |
| 88 | MP0005666_abnormal_adipose_tissue | 0.66094597 |
| 89 | MP0000613_abnormal_salivary_gland | 0.63518448 |
| 90 | MP0009745_abnormal_behavioral_response | 0.63232501 |
| 91 | MP0003448_altered_tumor_morphology | 0.63019813 |
| 92 | MP0000647_abnormal_sebaceous_gland | 0.61241670 |
| 93 | MP0002098_abnormal_vibrissa_morphology | 0.59229415 |
| 94 | MP0000920_abnormal_myelination | 0.58040651 |
| 95 | MP0002405_respiratory_system_inflammati | 0.57822758 |
| 96 | MP0001216_abnormal_epidermal_layer | 0.55658473 |
| 97 | MP0000465_gastrointestinal_hemorrhage | 0.55039784 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 0.54258789 |
| 99 | MP0002735_abnormal_chemical_nociception | 0.54051598 |
| 100 | MP0002572_abnormal_emotion/affect_behav | 0.53738625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased density of long bones (HP:0006392) | 7.50715589 |
| 2 | Thoracolumbar scoliosis (HP:0002944) | 4.79953408 |
| 3 | Hip dysplasia (HP:0001385) | 4.64253939 |
| 4 | Neoplasm of the heart (HP:0100544) | 4.59814317 |
| 5 | Alveolar cell carcinoma (HP:0006519) | 3.87041244 |
| 6 | Ependymoma (HP:0002888) | 3.70833060 |
| 7 | Spastic diplegia (HP:0001264) | 3.45192691 |
| 8 | Neoplasm of the tracheobronchial system (HP:0100552) | 3.33383659 |
| 9 | Agnosia (HP:0010524) | 3.25577963 |
| 10 | Hyperglycinuria (HP:0003108) | 3.24598244 |
| 11 | Enlarged epiphyses (HP:0010580) | 3.18918802 |
| 12 | Atonic seizures (HP:0010819) | 3.13899660 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 3.11583848 |
| 14 | Abnormality of binocular vision (HP:0011514) | 3.09920737 |
| 15 | Diplopia (HP:0000651) | 3.09920737 |
| 16 | Hydroxyprolinuria (HP:0003080) | 3.09213962 |
| 17 | Abnormality of proline metabolism (HP:0010907) | 3.09213962 |
| 18 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.07365289 |
| 19 | Disinhibition (HP:0000734) | 3.03564515 |
| 20 | Retinal dysplasia (HP:0007973) | 2.95532181 |
| 21 | Prominent nose (HP:0000448) | 2.82645721 |
| 22 | Pendular nystagmus (HP:0012043) | 2.79023844 |
| 23 | Abnormality of the astrocytes (HP:0100707) | 2.73084777 |
| 24 | Astrocytoma (HP:0009592) | 2.73084777 |
| 25 | Long toe (HP:0010511) | 2.61456263 |
| 26 | Horizontal nystagmus (HP:0000666) | 2.53981124 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 2.52524607 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.52524607 |
| 29 | Hemiparesis (HP:0001269) | 2.51922682 |
| 30 | Broad face (HP:0000283) | 2.47534804 |
| 31 | Joint swelling (HP:0001386) | 2.46152814 |
| 32 | Vacuolated lymphocytes (HP:0001922) | 2.46114732 |
| 33 | Amyloidosis (HP:0011034) | 2.38647320 |
| 34 | Glioma (HP:0009733) | 2.35652162 |
| 35 | Radial bowing (HP:0002986) | 2.35420499 |
| 36 | Agitation (HP:0000713) | 2.34271490 |
| 37 | Femoral bowing (HP:0002980) | 2.31432244 |
| 38 | Difficulty climbing stairs (HP:0003551) | 2.30222037 |
| 39 | Pheochromocytoma (HP:0002666) | 2.29454014 |
| 40 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.29127994 |
| 41 | Severe short stature (HP:0003510) | 2.25812081 |
| 42 | Inappropriate behavior (HP:0000719) | 2.25129838 |
| 43 | Loss of speech (HP:0002371) | 2.24827588 |
| 44 | Blepharitis (HP:0000498) | 2.22443017 |
| 45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.22259166 |
| 46 | Apathy (HP:0000741) | 2.21150265 |
| 47 | Cranial hyperostosis (HP:0004437) | 2.20978646 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.17583124 |
| 49 | Conjugated hyperbilirubinemia (HP:0002908) | 2.15108566 |
| 50 | Growth hormone excess (HP:0000845) | 2.14547109 |
| 51 | Thick nail (HP:0001805) | 2.13659404 |
| 52 | Sensorimotor neuropathy (HP:0007141) | 2.09127013 |
| 53 | Fibular aplasia (HP:0002990) | 2.08152162 |
| 54 | Broad-based gait (HP:0002136) | 2.06941492 |
| 55 | Abnormality of macular pigmentation (HP:0008002) | 2.06647672 |
| 56 | Decreased muscle mass (HP:0003199) | 2.05895571 |
| 57 | Basal ganglia calcification (HP:0002135) | 2.05123634 |
| 58 | Increased cerebral lipofuscin (HP:0011813) | 2.03406491 |
| 59 | Dysostosis multiplex (HP:0000943) | 2.01817020 |
| 60 | Abnormality of glycolipid metabolism (HP:0010969) | 2.01455458 |
| 61 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.01455458 |
| 62 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.01455458 |
| 63 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.00780910 |
| 64 | Hemoptysis (HP:0002105) | 1.98610871 |
| 65 | Hepatosplenomegaly (HP:0001433) | 1.98434626 |
| 66 | Polyneuropathy (HP:0001271) | 1.98257299 |
| 67 | Pelvic girdle muscle weakness (HP:0003749) | 1.97354335 |
| 68 | Erythema (HP:0010783) | 1.93641946 |
| 69 | Shoulder girdle muscle weakness (HP:0003547) | 1.92521055 |
| 70 | Gangrene (HP:0100758) | 1.91848943 |
| 71 | Diminished motivation (HP:0000745) | 1.91550215 |
| 72 | Absence seizures (HP:0002121) | 1.90513506 |
| 73 | Difficulty running (HP:0009046) | 1.88000278 |
| 74 | Abolished electroretinogram (ERG) (HP:0000550) | 1.87938433 |
| 75 | Dialeptic seizures (HP:0011146) | 1.86540116 |
| 76 | Hemiplegia (HP:0002301) | 1.84338432 |
| 77 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.82941295 |
| 78 | Myocardial infarction (HP:0001658) | 1.82389654 |
| 79 | Hyperventilation (HP:0002883) | 1.82118806 |
| 80 | Poikiloderma (HP:0001029) | 1.80702579 |
| 81 | Abnormality of the 2nd finger (HP:0004100) | 1.79494337 |
| 82 | Constricted visual fields (HP:0001133) | 1.79149143 |
| 83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.79105603 |
| 84 | Abnormality of the pleura (HP:0002103) | 1.78913864 |
| 85 | Calf muscle hypertrophy (HP:0008981) | 1.78676833 |
| 86 | Prolonged neonatal jaundice (HP:0006579) | 1.77696511 |
| 87 | Pustule (HP:0200039) | 1.76009557 |
| 88 | Neuroendocrine neoplasm (HP:0100634) | 1.75569330 |
| 89 | Prominent supraorbital ridges (HP:0000336) | 1.73259513 |
| 90 | Recurrent bacterial skin infections (HP:0005406) | 1.71456113 |
| 91 | Restrictive lung disease (HP:0002091) | 1.71401954 |
| 92 | Renal cortical cysts (HP:0000803) | 1.70580468 |
| 93 | Ureteral stenosis (HP:0000071) | 1.68877921 |
| 94 | Erythroderma (HP:0001019) | 1.66715270 |
| 95 | Vasculitis (HP:0002633) | 1.65816944 |
| 96 | Abnormality of the nasal septum (HP:0000419) | 1.64600183 |
| 97 | Short tibia (HP:0005736) | 1.62884748 |
| 98 | Neuronal loss in central nervous system (HP:0002529) | 1.61495671 |
| 99 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.60694279 |
| 100 | Spondylolisthesis (HP:0003302) | 1.58757629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERBB4 | 6.87027479 |
| 2 | IRAK3 | 6.39342639 |
| 3 | FLT3 | 2.88425528 |
| 4 | PKN1 | 2.72239773 |
| 5 | MAP3K14 | 2.69214003 |
| 6 | TAOK1 | 2.59917097 |
| 7 | MST1R | 2.59430114 |
| 8 | TLK1 | 2.37093200 |
| 9 | ZAK | 2.34239510 |
| 10 | PIK3CA | 2.33537801 |
| 11 | TTN | 2.17819036 |
| 12 | MAP4K1 | 1.96149455 |
| 13 | TBK1 | 1.90810804 |
| 14 | IKBKB | 1.85997012 |
| 15 | MET | 1.78857486 |
| 16 | MAPK11 | 1.73027029 |
| 17 | CDK8 | 1.72703877 |
| 18 | RPS6KA4 | 1.54290407 |
| 19 | MAP4K2 | 1.52072418 |
| 20 | TESK1 | 1.46290788 |
| 21 | CSF1R | 1.37939175 |
| 22 | MAP2K7 | 1.33929824 |
| 23 | ERBB2 | 1.31409830 |
| 24 | SIK3 | 1.27259312 |
| 25 | LIMK1 | 1.21252756 |
| 26 | BRD4 | 1.19291733 |
| 27 | MATK | 1.15274875 |
| 28 | PRKCE | 1.13011032 |
| 29 | CAMK2G | 1.11710401 |
| 30 | TTK | 1.09098153 |
| 31 | CHUK | 1.05830715 |
| 32 | NME2 | 1.05694757 |
| 33 | MAPKAPK3 | 1.04033957 |
| 34 | SRPK1 | 0.99724759 |
| 35 | TXK | 0.98628288 |
| 36 | TRPM7 | 0.96683632 |
| 37 | NTRK3 | 0.91587280 |
| 38 | NEK1 | 0.89528747 |
| 39 | FRK | 0.83395355 |
| 40 | IRAK1 | 0.82845260 |
| 41 | BMX | 0.79504436 |
| 42 | FGR | 0.74007311 |
| 43 | MARK1 | 0.71643707 |
| 44 | PKN2 | 0.69681635 |
| 45 | TAOK2 | 0.69509848 |
| 46 | ABL1 | 0.69195176 |
| 47 | PDGFRB | 0.69167327 |
| 48 | DDR2 | 0.66682329 |
| 49 | IKBKE | 0.65297402 |
| 50 | MAP3K9 | 0.63857642 |
| 51 | EPHA2 | 0.63368687 |
| 52 | RPS6KA2 | 0.62139013 |
| 53 | IRAK4 | 0.59602355 |
| 54 | PRKG2 | 0.59434600 |
| 55 | ADRBK2 | 0.57750456 |
| 56 | PBK | 0.54772944 |
| 57 | STK38L | 0.54624499 |
| 58 | CDC42BPA | 0.53831325 |
| 59 | EGFR | 0.51114787 |
| 60 | JAK1 | 0.50774476 |
| 61 | MAP3K4 | 0.50189543 |
| 62 | UHMK1 | 0.49549657 |
| 63 | STK24 | 0.47778095 |
| 64 | LATS2 | 0.47554248 |
| 65 | BMPR2 | 0.47261398 |
| 66 | BLK | 0.46944815 |
| 67 | BCR | 0.46623805 |
| 68 | STK4 | 0.45947343 |
| 69 | TRIM28 | 0.45161214 |
| 70 | ERBB3 | 0.45065250 |
| 71 | BUB1 | 0.44342433 |
| 72 | IRAK2 | 0.43493618 |
| 73 | CAMK2A | 0.42617012 |
| 74 | JAK2 | 0.42568826 |
| 75 | TAOK3 | 0.40938068 |
| 76 | JAK3 | 0.40491670 |
| 77 | KDR | 0.40207392 |
| 78 | MAPKAPK2 | 0.39297798 |
| 79 | MAP3K5 | 0.37136303 |
| 80 | RPS6KC1 | 0.36727251 |
| 81 | RPS6KL1 | 0.36727251 |
| 82 | ALK | 0.36072890 |
| 83 | PDGFRA | 0.35921383 |
| 84 | PRKD2 | 0.35619495 |
| 85 | CSNK1G2 | 0.35504262 |
| 86 | ABL2 | 0.35276837 |
| 87 | LCK | 0.34861124 |
| 88 | ROCK1 | 0.34760777 |
| 89 | PRKCZ | 0.34223898 |
| 90 | PRKCD | 0.34114119 |
| 91 | DAPK2 | 0.30508533 |
| 92 | PIK3CG | 0.30158846 |
| 93 | CAMK1D | 0.30059254 |
| 94 | PINK1 | 0.29407793 |
| 95 | GRK7 | 0.28250364 |
| 96 | MST4 | 0.28139868 |
| 97 | KIT | 0.28094009 |
| 98 | SYK | 0.27880915 |
| 99 | SIK1 | 0.27356233 |
| 100 | INSR | 0.27297402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 4.29911078 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.28624930 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.49141554 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.33187310 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.28710519 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.01038376 |
| 7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.96309308 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.86427100 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.85705550 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.61592761 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.58296760 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.11317412 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 2.02500720 |
| 14 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 2.00851947 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.84436282 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.76031690 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72459815 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.72232720 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.67432206 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.62832784 |
| 21 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.59816532 |
| 22 | Galactose metabolism_Homo sapiens_hsa00052 | 1.56476279 |
| 23 | Nicotine addiction_Homo sapiens_hsa05033 | 1.53840213 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.49376706 |
| 25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.39728922 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.28028165 |
| 27 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.24792619 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.24235055 |
| 29 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.19103234 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.16707613 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.16343680 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.16193464 |
| 33 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.13055922 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.09696690 |
| 35 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.07267027 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.03382801 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.02657398 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.99654666 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.95564229 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94449893 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.92436422 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92172071 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90853579 |
| 44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.85928608 |
| 45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85436152 |
| 46 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.85000019 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83718794 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 0.83717998 |
| 49 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.83330079 |
| 50 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.82652618 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.82498868 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81356520 |
| 53 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.79777840 |
| 54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.79264498 |
| 55 | RNA polymerase_Homo sapiens_hsa03020 | 0.78465646 |
| 56 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.74510569 |
| 57 | Lysosome_Homo sapiens_hsa04142 | 0.67607148 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 0.65833395 |
| 59 | Proteasome_Homo sapiens_hsa03050 | 0.65778331 |
| 60 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65506340 |
| 61 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.65329614 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56933663 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55087666 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50283950 |
| 65 | Malaria_Homo sapiens_hsa05144 | 0.48500758 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.47639277 |
| 67 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45994815 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.45585018 |
| 69 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41926310 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.41878290 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.40618873 |
| 72 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39582608 |
| 73 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.39400130 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.38856164 |
| 75 | Taste transduction_Homo sapiens_hsa04742 | 0.38472400 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36595104 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.35201532 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33540019 |
| 79 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.33260012 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32688801 |
| 81 | Protein export_Homo sapiens_hsa03060 | 0.29821420 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29298488 |
| 83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.29250274 |
| 84 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.28485160 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28409623 |
| 86 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.27572020 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26200723 |
| 88 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26064672 |
| 89 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.24355190 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.23716492 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22938666 |
| 92 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.21860926 |
| 93 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.20338025 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.19960445 |
| 95 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.19764147 |
| 96 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.17590756 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16886261 |
| 98 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.16727391 |
| 99 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.16363550 |
| 100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.15323370 |

